Jordan B. King, PharmD, MSCI

Languages

  • English

Academic Information

  • Departments: Population Health Sciences - Assistant Professor
  • Divisions: Health System Innovation and Research

Education History

Type School Degree
Fellowship University of Utah
Health Economics and Outcomes Research
Fellow
Graduate Training University of Utah School of Medicine
M.S.C.I
Doctoral Training Roseman University of Health Sciences, College of Pharmacy
Medicine
Pharm.D.

Selected Publications

Journal Article

  1. Colvin CL, Poudel B, Bress AP, Derington CG, King JB, Wen Y, Chen L, Bittner V, Brown TM, Monda KL, Mues KE, Rosenson RS, Jackson EA, Muntner P, Colantonio LD (2021). Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction. J Clin Lipidol, 15(5), 665-673.
  2. Bellows BK, Zhang Y, Zhang Z, Lloyd-Jones DM, Bress AP, King JB, Kolm P, Cushman WC, Johnson KC, Tamariz L, Oelsner EC, Shea S, Newman AB, Ives DG, Couper D, Moran AE, Weintraub WS (2021). Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data. J Am Heart Assoc, 10(10), e020361.
  3. Li S, Schwartz JE, Shimbo D, Muntner P, Shikany JM, Booth JN 3rd, Allen NB, Jaeger BC, Bress AP, King JB, Clark D 3rd, Butler KR, Correa A, Moran AE, Bellows BK, Zhang Y (2021). Estimated Prevalence of Masked Asleep Hypertension in US Adults. JAMA Cardiol, 6(5), 568-573.
  4. Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP (2021). Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One, 16(4), e0248080.
  5. Derington CG, Colantonio LD, Herrick JS, Cook J, King JB, Rosenson RS, Poudel B, Monda KL, Navar AM, Mues KE, Stevens VW, Nelson RE, Vanneman ME, Muntner P, Bress AP (2021). Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans. J Am Heart Assoc, 10(8), e019254.
  6. Caffiero NA, Nickman NA, Drews FA, King JB, Moorman K, Tyler LS (2020). Reduction of phone interruptions post implementation of a central call center in community pharmacies of an academic health system. Am J Health Syst Pharm, 78(2), 113-121.
  7. Derington CG, King JB, Delate T, Botts SR, Kroehl M, Kao DP, Trinkley KE (2020). Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety. PLoS One, 15(12), e0243371.
  8. Colvin CL, King JB, Oparil S, Wright JT Jr, Ogedegbe G, Mohanty A, Hardy ST, Huang L, Hess R, Muntner P, Bress A (2020). Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report. JAMA Netw Open, 3(11), e2025127.
  9. Shokoohi H, Boniface KS, Loesche MA, Duggan NM, King JB (2019). Development of a nomogram to predict small bowel obstruction using point-of-care ultrasound in the emergency department. Am J Emerg Med, 38(11), 2356-2360.
  10. An J, Derington CG, Luong T, Olson KL, King JB, Bress AP, Jackevicius CA (2020). Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges. Curr Hypertens Rep, 22(11), 95.
  11. Jones AE, King JB, Kim K, Witt DM (2020). The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring. J Thromb Thrombolysis, 50(3), 739-745.
  12. Kuye R, Riggs C, King J, Heilmann R, Kurz D, Milchak J (2020). Thyroid Stimulating Hormone Stability in Patients Prescribed Synthetic or Desiccated Thyroid Products: A Retrospective Study. Ann Fam Med.
  13. Bryant KB, Sheppard JP, Ruiz-Negrn N, Kronish IM, Fontil V, King JB, Pletcher MJ, Bibbins-Domingo K, Moran AE, McManus RJ, Bellows BK (2020). Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure Control. J Am Heart Assoc, 9(15), e016174.
  14. Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP (2020). Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension, 75(4), 973-981.
  15. Boniface KS, King JB, LeSaux MA, Haciski SC, Shokoohi H (2019). Diagnostic Accuracy and Time-Saving Effects of Point-of-Care Ultrasonography in Patients With Small Bowel Obstruction: A Prospective Study. Ann Emerg Med, 75(2), 246-256.
  16. Pajewski NM, Berlowitz DR, Bress AP, Callahan KE, Cheung AK, Fine LJ, Gaussoin SA, Johnson KC, King J, Kitzman DW, Kostis JB, Lerner AJ, Lewis CE, Oparil S, Rahman M, Reboussin DM, Rocco MV, Snyder JK, Still C, Supiano MA, Wadley VG, Whelton PK, Wright JT Jr, Williamson JD (2019). Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. J Am Geriatr Soc, 68(3), 496-504.
  17. Derington CG, King JB, Bryant KB, McGee BT, Moran AE, Weintraub WS, Bellows BK, Bress AP (2019). Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care. Curr Hypertens Rep, 21(12), 91.
  18. Mohanty AF, Levitan EB, Dodson JA, Vardeny O, King JB, LaFleur J, He T, Patterson OV, Alba PR, Russo PA, Choi ME, Bress AP (2019). Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan. Circ Heart Fail, 12(11), e005691.
  19. Owlia M, Dodson JA, King JB, Derington CG, Herrick JS, Sedlis SP, Crook J, DuVall SL, LaFleur J, Nelson R, Patterson OV, Shah RU, Bress AP (2019). Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina. J Am Heart Assoc, 8(15), e012811.
  20. Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, Chonchol M, Cushman WC, Foy CG, Herring CT, Katz LA, Krousel-Wood M, Pajewski NM, Tamariz L, King JB, SPRINT Research Group (2019). Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT. Hypertension, HYPERTENSIONAHA11912907.
  21. Bellows BK, Ruiz-Negrn N, Bibbins-Domingo K, King JB, Pletcher MJ, Moran AE, Fontil V (2019). Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals. Circ Cardiovasc Qual Outcomes, 12(6), e005624.
  22. Chamberlain AM, Gong Y, Shaw KM, Bian J, Song WL, Linton MF, Fonseca V, Price-Haywood E, Guhl E, King JB, Shah RU, Puro J, Shenkman E, Pawloski PA, Margolis KL, Hernandez AF, Cooper-DeHoff RM (2019). PCSK9 Inhibitor Use in the Real World: Data From the National Patient-Centered Research Network. J Am Heart Assoc, 8(9), e011246.
  23. Ruiz-Negrn N, Menon J, King JB, Ma J, Bellows BK (2019). Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review. Pharmacoeconomics, 37(5), 669-688.
  24. Chelu MG, King JB, Kholmovski EG, Ma J, Gal P, Marashly Q, AlJuaid MA, Kaur G, Silver MA, Johnson KA, Suksaranjit P, Wilson BD, Han FT, Elvan A, Marrouche NF (2018). Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up Data. J Am Heart Assoc, 7(23), e006313.
  25. Bress AP, Dodson JA, King JB, Sauer BC, Reese T, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, LaFleur J (2018). Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. Am J Cardiol, 122(11), 1809-1816.
  26. Hawkins KL, King J, Delate T, Martinez K, McCool K, Clark NP (2018). Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service. J Manag Care Spec Pharm, 24(11), 1130-1137.
  27. King J, Bress A, Bellows B (2017). Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction. Ann Intern Med, 166(8), 606-607.
  28. Shokoohi H, Berry GW, Shahkolahi M, King J, King J, Salimian M, Poshtmashad A, Pourmand A (2016). The diagnostic utility of sonographic carotid flow time in determining volume responsiveness. J Crit Care, 38, 231-235.

Editorial

  1. Bress AP, King JB (2018). Optimizing Medical Therapy in Chronic Worsening HFrEF: A Long Way to Go. J Am Coll Cardiol, 73(8), 945-947.

Letter

  1. Delate T, Charlu M, Zhu S, Pai A, Clark NP, Witt DM, King JM, King JB (2020). Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism. [Letter to the editor]. Thromb Res, 196, 367-370.